ストックスクリーナーアプリを入手
87.55
0.26%
0.2474
前日終値:
$87.30
開ける：
$88.54
24時間の取引高:
107.79K
Relative Volume:
0.09
時価総額：
$9.76B
収益：
$13.38B
当期純損益:
$418.00M
株価収益率:
26.44
EPS:
3.3112
ネットキャッシュフロー:
$391.00M
1週間 パフォーマンス:
-2.54%
1か月 パフォーマンス:
-1.86%
6か月 パフォーマンス:
+14.41%
1年 パフォーマンス:
+25.85%
1日の値動き範囲:
$87.36
$88.79
1週間の範囲:
$87.11
$89.99
52週間の値動き範囲:
$61.95
$92.18
Henry Schein Inc Stock (HSIC) Company Profile
Compare HSIC vs MCK, COR, CAH, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
87.55 | 9.73B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
880.87 | 102.70B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
319.49 | 61.25B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
234.13 | 54.89B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
0.74 | 625.57M | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-16 | 開始されました | BTIG Research | Neutral |
| 2026-04-15 | 開始されました | Citigroup | Buy |
| 2026-02-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-08-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-25 | ダウングレード | Stifel | Buy → Hold |
| 2025-07-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 開始されました | Wells Fargo | Equal Weight |
| 2025-01-06 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-07-22 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-11-10 | アップグレード | Stifel | Hold → Buy |
| 2022-08-08 | アップグレード | UBS | Sell → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 再開されました | Credit Suisse | Outperform |
| 2022-01-31 | 開始されました | Morgan Stanley | Underweight |
| 2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 再開されました | Credit Suisse | Neutral |
| 2021-02-08 | 再開されました | Piper Sandler | Overweight |
| 2021-01-04 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | アップグレード | Goldman | Neutral → Buy |
| 2020-04-02 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | アップグレード | Evercore ISI | Underperform → In-line |
| 2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 開始されました | Wolfe Research | Underperform |
| 2019-05-15 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-01-17 | 開始されました | UBS | Sell |
| 2019-01-03 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2019-01-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-10-25 | ダウングレード | Edward Jones | Hold → Sell |
| 2018-10-19 | 再開されました | Goldman | Neutral |
| 2018-10-04 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-08-07 | 繰り返されました | Stifel | Hold |
| 2018-04-24 | ダウングレード | Goldman | Buy → Neutral |
| 2018-04-04 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
すべてを表示
Henry Schein Inc (HSIC) 最新ニュース
Henry Schein stock heads into the open after a 1.0% daily loss - ad-hoc-news.de
Henry Schein Executive Andrea Albertini Reports Two Stock Disposals on September 8, 2026 - Kalkine Media
Tax withholding prompts Henry Schein (HSIC) insider to return shares - Stock Titan
Henry Schein stock holds steady after recent earnings update - ad-hoc-news.de
Precision Trading with Henry Schein Inc. (HSIC) Risk Zones - Stock Traders Daily
Henry Schein stock rises on a new distribution deal - ad-hoc-news.de
Henry Schein to Present at Baird Global Healthcare Conference - dentistrytoday.com
Henry Schein to Distribute Applied BioCode's MDx-3000 System in US - marketscreener.com
Applied BioCode Announces Distribution Agreement with Henry Schein - Business Wire
Henry Schein to Participate in Upcoming Investor Conference in September - Business Wire
How Investors May Respond To Henry Schein (HSIC) Distributing DermaSensor’s Skin Cancer Detection Device - webull.com
Henry Schein stock gains after strong Q2 2026 results and raised outlook - ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein stock gains institutional support as new diagnostic partnership advances strategy - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein Inc. helps children start the school year - Reading Eagle
Henry Schein stock rises after Q2 earnings beat - AD HOC NEWS
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why - finance.yahoo.com
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report? - finance.yahoo.com
Henry Schein shares technical analysis: Resistance test at $92.68 in focus - Traders Union
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Eastern Progress
Is Henry Schein (HSIC) Stock Undervalued Right Now? - Yahoo Finance
Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available? - Yahoo Finance
Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein, Inc. (HSIC) Stock Report: Analyst Consensus Points to 10.95% Potential Upside - DirectorsTalk Interviews
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - fortune.com
Henry Schein stock holds steady as 2026 outlook is raised and Q2 earnings beat - Ad-hoc-news.de
What Are Wall Street Analysts' Target Price for Henry Schein Stock? - Yahoo Finance
Is HSIC Worth Buying as Growth Improves but Execution Risks Persist? - TradingView
Henry Schein, Special Olympics re-up partnership - HME News
Henry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - marketscreener.com
BTIG Adjusts Price Target on Henry Schein to $110 From $100, Maintains Buy Rating - marketscreener.com
Henry Schein and Special Olympics Renew Partnership Through 2030 - Orthodontic Products
Henry Schein stock holds steady as higher-margin Q2 2026 lifts guidance - AD HOC NEWS
Building a healthier future together: Henry Schein and Special Olympics renew partnership through 2030 - Special Olympics
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates - TradingView
Empowered Funds LLC Has $851,000 Position in Henry Schein, Inc. $HSIC - MarketBeat
Buckland Partners Management Co LLC Makes New Investment in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein stock holds near a 52-week high after a Buy upgrade - Ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential Amidst a 8.68% Upside - DirectorsTalk Interviews
Henry Schein (NASDAQ:HSIC) Rating Increased to Buy at Wall Street Zen - MarketBeat
How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors - simplywall.st
Form 144 | Henry Schein(HSIC.US) Insider Proposes to Sell 3.18 Million in Common Stocks - Moomoo
Henry Schein (HSIC) insider Bergman plans $3.18M sale under Form 144 - Stock Titan
HSIC|Henry Schein Inc|Price:90.000|Chg%:+0.230 - tradingkey.com
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Why Henry Schein's (NASDAQ:HSIC) Earnings Are Better Than They Seem - Moomoo
Henry Schein Inc (HSIC) 財務データ
収益
当期純利益
現金流量
EPS
1.34%
0.46%
大文字化:
|
ボリューム (24 時間):